Medifast Inc

Medifast Inc (MED) Stock Analysis

$12.730

-0.406 (-3.19%)At close

Loading chart…
High
13.220
Open
13.080
VWAP
12.81
Volume
152.10K
Mkt Cap
230.99M
Low
12.470
Amount
1.95M
EV/EBITDA, TTM
-1.79

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA. It sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories. Its product line includes approximately 74 consumable options, including, but not limited to, bars, cereal, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. Its OPTAVIA ASCEND mini meals deliver nutrition that gives clients’ bodies what they need to - whether losing weight on a GLP-1 medication or in weight management mode. Its OPTAVIA Fuelings contain approximately 24 vitamins and minerals, high quality, complete protein, and no colors, flavors or sweeteners from artificial sources.

AI analysis of Medifast Inc (MED)

Hold

Medifast Inc (MED) is currently trading at $12.53, showing a recent upward trend with a 5-day change of +3.47%. However, the company has reported significant losses, with a forward P/E of 12.48 indicating potential recovery but also reflecting ongoing challenges. The RSI is at 67.72, suggesting it may be nearing overbought territory. The main risk is the substantial net income loss of $17.5 million reported for Q3 2026, which raises concerns about its financial stability.

Analyst Ratings (2)

Buy
1 Buy
1 Hold
0 Sell
Current: 12.73
Low
—
Average
—
High
—

Stephens

2026-02-19

Price Target

$12

Equal Weight

DA Davidson

2025-02-19

Price Target

$17

Hold

DA Davidson

2024-11-05

Price Target

$17

Hold

DA Davidson

2024-07-22

Price Target

$18

Sell

DA Davidson

2024-06-05

Price Target

$18

Sell

Valuation Metrics

The current forward P/E ratio for Medifast Inc (MED) is 12.48, compared to its 5-year average forward P/E of 10.08.

Forward P/E

Fair
5Y Average P/E
10.08
Current P/E
12.48
Overvalued
76.00
Undervalued
-55.84

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
1.60
Current EV/EBITDA
-1.79
Overvalued
15.94
Undervalued
-12.73

Forward P/S

Fair
5Y Average P/S
0.72
Current P/S
0.54
Overvalued
1.07
Undervalued
0.37

Alphio AI Price Scenarios for MED

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%MED

$7.77

Scenario price

B

Base

Base · 50%MED

$7.58

Scenario price

B

Bear

Bear · 25%MED

$5.48

Scenario price

Events Timeline

2026-10-26 (ET)

08:30:00

Company Expects 2026 Revenue Between $280 Million and $300 Million

08:30:00

Medifast Reports Q3 Revenue of $72.05M

08:30:00

Sees Q4 Revenue of $55M-$75M

2026-08-27 (ET)

09:00:00

Medifast Launches Metabolic Health Institute

2026-08-03 (ET)

19:30:00

Stock Futures Broadly Higher, Oil Prices Slip

News

MED FAQ — answered by Alphio AI

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA. It sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories. Its product line includes approximately 74 consumable options, including, but not limited to, bars, cereal, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. Its OPTAVIA ASCEND mini meals deliver nutrition that gives clients’ bodies what they need to - whether losing weight on a GLP-1 medication or in weight management mode. Its OPTAVIA Fuelings contain approximately 24 vitamins and minerals, high quality, complete protein, and no colors, flavors or sweeteners from artificial sources. It operates in the Consumer Non-Cyclicals sector (MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS industry).

Medifast Inc (MED) is currently trading at $12.53, showing a recent upward trend with a 5-day change of +3.47%. However, the company has reported significant losses, with a forward P/E of 12.48 indicating potential recovery but also reflecting ongoing challenges. The RSI is at 67.72, suggesting it may be nearing overbought territory. The main risk is the substantial net income loss of $17.5 million reported for Q3 2026, which raises concerns about its financial stability.

2 analysts cover MED: 1 rate it Buy, 1 Hold and 0 Sell.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading